Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.81 HKD | +1.44% | +10.63% | -19.02% |
25/04 | Sino Biopharm Completes Phase I Study of Hepatitis B Drug | MT |
22/04 | Lull in Geopolitical Tensions Lifts Asian Stock Markets | MT |
Business Summary
- chemical medicine products and biopharmaceutical drugs (97.6%);
- other (2.4%).
Number of employees: 25,806
Sales per Business
HKD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Modernised Chinese Medicines and Chemical Medicines
98.1
%
| 31,613 | 97.7 % | 32,830 | 98.1 % | +3.85% |
Others
1.9
%
| 760 | 2.3 % | 638 | 1.9 % | -16.05% |
Sales per region
HKD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 32,374 | 100.0 % | 33,468 | 100.0 % | +3.38% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
S Y Tse
CEO | Chief Executive Officer | 29 | 23/19/23 |
Ping Tse
FOU | Founder | 72 | 02/00/02 |
Chun Ling Li
DFI | Director of Finance/CFO | 53 | - |
Ming Qin Li
BRD | Director/Board Member | 66 | 01/97/01 |
Hsin Tse
BRD | Director/Board Member | 54 | 01/95/01 |
Sean Chen
PRN | Corporate Officer/Principal | 46 | 01/22/01 |
Qian Li
PRN | Corporate Officer/Principal | - | 01/09/01 |
Philip Duong
PRN | Corporate Officer/Principal | 34 | 01/20/01 |
Benjamin Toogood
PRN | Corporate Officer/Principal | 48 | 01/21/01 |
Oi Nin Chan
SEC | Corporate Secretary | 56 | 25/15/25 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ping Tse
FOU | Founder | 72 | 02/00/02 |
Director/Board Member | 60 | 01/05/01 | |
Hsin Tse
BRD | Director/Board Member | 54 | 01/95/01 |
Da Kui Li
BRD | Director/Board Member | 80 | 01/04/01 |
Ming Qin Li
BRD | Director/Board Member | 66 | 01/97/01 |
Lu Fu Zhang
BRD | Director/Board Member | 67 | 20/15/20 |
Hong Lu
BRD | Director/Board Member | 55 | 20/15/20 |
Theresa Tse
CHM | Chairman | 32 | 30/15/30 |
Kwok Tung Li
BRD | Director/Board Member | 69 | 31/20/31 |
S Y Tse
CEO | Chief Executive Officer | 29 | 23/19/23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 18,801,217,230 | 9,740,976,595 ( 51.81 %) | 0 | 51.81 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
1,376,000 | 0.27% | 1,775,728 $ |
Company contact information
Sino Biopharmaceutical Ltd.
Unit 09, 41st Floor, Office Tower Convention Plaza
, Hong Kong
+852 2802 9886
http://www.sinobiopharm.comSector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.02% | 6.49B | |
+26.47% | 661B | |
+26.74% | 566B | |
-6.33% | 352B | |
+19.35% | 332B | |
+4.23% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-4.04% | 145B |
- Stock Market
- Equities
- 1177 Stock
- Company Sino Biopharmaceutical Limited